Expression of Aromatase Cytochrome P450 and Cyclooxygenase-2 in Endometriosis
Observational
OA: closed
CC0
AI-generated summary
This study found that aromatase cytochrome P450 and cyclooxygenase-2 are strongly expressed in ectopic and eutopic endometrium of women with endometriosis, suggesting their potential role in disease progression and as diagnostic markers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To study the expression and significance of aromatase cytochome P450(P450arom) and cyclooxygenase-2 in the ectopic and eutopic endometrium of women with endometriosis.Methods The expression level for P450arom and COX-2 was determined by immunohistochemistry in 30 ovarian endometriosis patients and 30 normal individuals as control.Results The expression of P450arom and COX-2 in the ectopic and eutopic endometrium of women with endometriosis was strongly positive, whereas the level of COX-2 was low and no expression of P450arom was found in the normal endometrium. The expression of P450arom and COX-2 in the ectopic and eutopic endometrium was not correlated to menstrual phase. The expression of COX-2 in the secretory phase was significantly higher than that in the proliferative phase in normal endometrium.Conclusion High level expression of P450arom and COX-2 may be closely related to the invasion and progression of endometriosis. Inhibition of the activity of P450arom and COX-2 may be used as a novel method for treatment of endometriosis. Determination the expression of P450arom may be conducted for the diagnosis of endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK